生命科学资讯

Is It Time To Reconsider Illumina (ILMN) After Mixed Multi Year Share Performance? - Yahoo Finance

Illumina (ILMN) Valuation Check After CMS Reimbursement Milestone In Precision Oncology - simplywall.st

Baillie Gifford & Co. Lowers Stake in Illumina, Inc. $ILMN - MarketBeat

Illumina’s billion cell atlas tries to solve artificial intelligence’s data bottleneck in biology - 2 Minute Medicine

Illumina, Inc. $ILMN Shares Sold by Teacher Retirement System of Texas - MarketBeat

Universal Beteiligungs und Servicegesellschaft mbH Purchases 40,166 Shares of Illumina, Inc. $ILMN - MarketBeat

$4.5 Billion Whole Genome Sequencing Market Outlook, 2031 Featuring Profiles of Illumina, Thermo Fisher Scientific, Oxford Nanopore Technologies and Other Leading Players - Yahoo Finance Singapore

Why Illumina (ILMN) Is Up 5.9% After CMS Backs TruSight Oncology Comprehensive Reimbursement - simplywall.st

Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing

Dubai Health embraces genomics to advance care and research - Illumina

Illumina (NASDAQ:ILMN) Sets New 52-Week High - Here's What Happened - MarketBeat

Illumina and Powell Gilbert in love with Lisbon - JUVE Patent

Customer Engagement Center - Illumina

Optimizing Illumina Long-Read Whole Genome Sequencing of Salivary DNA Using Oragene™ Collection Devices - the-scientist.com

Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down - Nasdaq

Medicare to cover $2,989.55 Illumina genomic cancer test - Stock Titan

Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology - PR Newswire

Stifel raises Illumina stock price target to $155 on growth outlook - Investing.com

GRAIL Inc. - Illumina's Divested Holy Grail (NASDAQ:GRAL) - Seeking Alpha

Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside - Insider Monkey